X4 Pharmaceuticals, Inc.
XFORNASDAQHealthcareBiotechnology
As of Oct 15, 2026 close
- Market cap
- $333.55M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $2.43$4.83
- Volume (live)
- -
- Avg. volume (3M)
- 1.06M
X4 Pharmaceuticals (XFOR) Stock Price & Financial Analysis
X4 Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.48 - $2.66 |
|---|---|
| 52-Week High | $4.83 |
| 52-Week Low | $2.43 |
| Open | $2.48 |
| Volume (last close) | 549.49K |
| Average Volume (3M) | 1.06M |
| Revenue (TTM) | 15.85M |
|---|---|
| Net Income (TTM) | -90.14M |
| Free Cash Flow (TTM) | -83.74M |
| EPS (TTM) | −$0.89 |
| Profit Margin | -568.80% |
| Operating Margin | -554.71% |
| Return on Equity (ROE) | -57.98% |
| Debt to Equity | 0.50 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 333.55M |
|---|---|
| Shares Outstanding | 126.34M |
| Price to Sales (P/S) | 21.05 |
| Price to Book (P/B) | 2.15 |
| EV/EBITDA | -2.70 |
| 50-Day MA | $3.61 |
|---|---|
| 200-Day MA | $3.85 |
| 1-Year Change | −11.11% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
X4 Pharmaceuticals at a Glance
As of the Oct 15, 2026 close, X4 Pharmaceuticals (XFOR) has a market capitalization of $333.55M. The stock trades at 21.1× sales. Over the trailing twelve months it lost $90.14M on revenue of $15.85M and burned $83.74M of free cash flow. Revenue fell 51.6% year over year.
As of its latest reported balance sheet, it holds $195.09M in cash and securities against $77.22M of debt, a net cash position of $117.87M.
X4 Pharmaceuticals does not currently pay a dividend.
The share price is down 11.1% over the past year. At $2.64 (the Oct 15, 2026 close) it sits near the bottom of its 52-week range of $2.43 to $4.83, below its 200-day moving average of $3.85.
Based on 1 professional analyst rating from the past 90 days, the consensus is Hold.
Frequently Asked Questions About X4 Pharmaceuticals
What is the current stock price for XFOR?
As of the Oct 15, 2026 close, XFOR stock trades at $2.64. The 52-week range is $2.43–$4.83, with a day range of $2.48–$2.65.
What is the P/E ratio for XFOR?
The P/E ratio (Price-to-Earnings) for XFOR is shown in the Key Statistics section. This valuation metric helps compare X4 Pharmaceuticals, Inc. to industry peers.
Does XFOR pay dividends?
X4 Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for XFOR?
Based on ratings from 1 professional analyst over the last 90 days, the consensus for XFOR is Hold.
What is the market cap of XFOR?
As of the Oct 15, 2026 close, X4 Pharmaceuticals's market capitalization is $333.5M, classifying it as a small-cap company. X4 Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.